Riskpilot← Back to searchSign inGet full accessOPTIKERNE PÅ VÆRNEDAMSVEJ ApS
APSActiveCVR 26033241Værnedamsvej 12Retail sale of medical and orthopaedic goods · NACE 4774Est. 20018 employees
Revenue 2025
DKK 7,1M
-5% vs 2024
EBITDA margin
38.6%
-15% vs 2024
Equity ratio
45.6%
Financial strength
Net profit 2025
DKK 2M
-18% vs 2024
| Revenue | DKK 7,1M | -5% |
| EBITDA | DKK 2,7M | -15% |
| Net profit | DKK 2M | -18% |
| Total assets | DKK 5M | -2% |
| Equity | DKK 2,3M | -14% |
| Employees | 8 | — |
Legal name
OPTIKERNE PÅ VÆRNEDAMSVEJ ApS
CVR number
26033241
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
26. april 2001
Share capital
DKK 200.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen
Company purpose
Selskabets formål er at drive handel med briller samt handel og service i øvrigt
Address
Værnedamsvej 12
Phone
+4533232900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6.878 | 7.219 | 6.374 | 7.450 | 7.080 |
| Staff expenses | -3.618 | -3.920 | -3.692 | -4.221 | -4.350 |
| EBITDA | 3.260 | 3.299 | 2.682 | 3.229 | 2.731 |
| Depreciation & amort. | -8 | -50 | -52 | -53 | -80 |
| EBIT | 3.252 | 3.249 | 2.630 | 3.176 | 2.650 |
| Net financials | 134 | -179 | -68 | -16 | -57 |
| Profit before tax | 3.386 | 3.070 | 2.562 | 3.160 | 2.594 |
| Tax | 745 | 678 | 575 | 698 | 572 |
| Net profit | 2.641 | 2.392 | 1.987 | 2.462 | 2.021 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6.995 | 5.984 | 5.192 | 5.106 | 5.026 |
| Equity | 3.694 | 3.086 | 2.187 | 2.668 | 2.290 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.294 | 2.890 | 3.000 | 2.437 | 2.737 |
| Total debt | 3.294 | 2.890 | 3.000 | 2.437 | 2.737 |
EBITDA margin
38.6%
This company
15.8%
Market median
+144% vs market
20212025
Equity ratio
45.6%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
88.3%
This company
18.4%
Market median
+380% vs market
20212025
Net profit margin
28.6%
This company
8.1%
Market median
+253% vs market
20212025
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20212025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TO Management | Management | 2023 |
MB Founder | Founder | 2001 |
ES Management | Management | 2001 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2023 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2023 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2022 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Daisyland Holding ApS
OPTIKERNE PÅ VÆRNEDAMSVEJ ApS Board members of OPTIKERNE PÅ VÆRNEDAMSVEJ ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torunn Otterås Haugland | Management | 0 companies |
| Michael Bohnsack | Founder | 0 companies |
| Elin Sørensen | Management | 0 companies |